Hong Kong-based investment firm HSG has entered into a definitive agreement to acquire the Avelox (moxifloxacin) antibiotics business from Bayer, for a deal value of roughly €160m – €260m. The acquisition includes the Avelox brand, intellectual property and commercial rights across all markets worldwide. Imprima Virtual Data Room was used to for the transaction.